If you’re looking for a great stock, all you need to do is ask yourself one question…

“Where am I spending my money?”

It takes almost no time to figure out.

In today’s short video, I’ll walk you through how to do it in less than 30 seconds – check it out below!

YOUR ACTION PLAN

Shares of Starbucks (Nasdaq: SBUX) have quietly gained 9% thus far in 2023 and 35% over the last 52 weeks. And if your mobile order is anything like mine, then it’s fair to say that the upside will continue. You see, back in the glory days, my typical order used to cost around $5.50. But now… I find myself paying $7 to $9. If the kids are in the car, the total jumps to $18.50 or more. And now that we’re entering summer – when high-margin cold drinks like Frappuccinos and Shaken Espressos become especially popular – I believe SBUX will continue to have plenty of upside. Throw in a forward annual dividend yield of 1.97%, and this is a stock that I like.

To get more trades like this in real time, I recommend joining Karim and me in The War Room. We use battle-tested strategies for bear and bull markets, and our methods work. We have a 76% win rate in 2023, and right now we are guaranteeing our members will receive 252 winning trades in their first 12 months.

Click here to join The War Room.

MONDAY MARKET MINUTE

• Can the Streak Continue? As of this morning, the Dow is on a four-week winning streak. The S&P 500 and Nasdaq have each posted four winning weeks in the past five. Can the winning continue now that we’re getting into the heart of earnings season? That’s what we’ll attempt to discover this week. Tracking.
• Biotech Stock Skyrockets in Premarket. Prometheus Biosciences (RXDX) was up 70% in premarket trading after Merck (MRK) agreed to acquire the company for $200 per share in cash for a total equity value of approximately $10.8 billion.
• Micron Ready to Pop. A series of higher lows has Barron’s now forecasting that a break of $65 could trigger a push up to $82 for MU.
• Room for More With Honeywell. We hit a winner on our HON call trade last week in The War Room, and I still like the “W” on the daily chart. The stock could extend up to $200 and above.
• Another Move on DocuSign. We also hit multiple winners on DOCU put trades last week, and I still believe that a retest of $50 is coming.